News

Its fresh funds will support its product development and international expansion efforts.

The company aims to help the self-testing market grow by licensing its core technology for transforming smartphones into IVD devices.

The startup scooped up $14 million in Series A funding in January 2021.

Hinge's new offering comes nearly two months after competitor SWORD Health announced its own pelvic health program.

Its web-based platform also guides patients to access appropriate medical care.

It plans to expand its coverage in the domestic market.

Also: Impiricus raises a $3 million seed, and health tech VC Flare Capital Partners closes its $350 million third fund.

The offering includes treatment and screening for prediabetes and Type 2 diabetes.

Coming nearly two years after the company's $100 million Series C, Biofourmis tallied its total raise at $445 million.

Also: Mental health-focused Spring Health hires Todd Hill from Headspace Health, Teladoc Health appoints Dr. Vidya Raman-Tangella as chief medical officer and WellSky appoints Dale Zurbay chief growth officer.